Supplier site
Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Genesis Research Group

Genesis Research Group is listed as a mid sized business research supplier in the Scientist.com network, with 1 site in 1 country.

View Genesis Research Group on Scientist.com

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Mid sized business

Clinical Consulting

Study Budgeting Consulting Request for Consulting Services

Clinical Trials

Bayesian Adaptive Trial Design Bayesian adaptive trial design allows real-time adjustments to clinical trials based on ongoing data analysis, enhancing flexibility and efficiency.
Clinical Trial Simulation and Forecasting Using of computational models to predict the outcomes, optimize designs, and evaluate the feasibility of clinical trials before they are conducted.
Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.
Statistical Analysis Planning Technical and detailed elaboration of the principal features of the analysis described in the protocol, and includes detailed procedures for executing the statistical analysis of the primary and secondary variables...
Synthetic Control Arm Creation Using RWD Using patient data from sources like electronic health records or claims databases to construct a comparator group for clinical trials, instead of enrolling a separate group of control patients.

Data Science/Bioinformatics

RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data

Disease Models

Disease Simulation Modeling Disease Simulation Modeling

Drug Development

Consulting Services Work with consultants who provide expert advice in various areas of research and technology.

HEOR

Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.

Show all 12 in HEOR 6 more

HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Show all 109 services 94 more

Market Access

Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...

Show all 18 in Market Access 12 more

Life Science Reports Life Science reports
Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
Pharmaceutical Reports Pharmaceutical Reports
Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting
Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

Abstracts Request services related to the writing and review of abstracts
Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
Data Visualization Visualize data collected from clinical trials and/or clinical research.
HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
KEE Identification, Mapping & Engagement Planning Systematic process to identify, categorize, and strategically plan outreach to Key External Experts (KEEs) based on their influence, specialization, and research activity.
Manuscript Co-Authorship and Publications Planning Manuscript co-authorship and publications planning involve collaborating among researchers to write, organize, and strategize the submission and publication of scientific findings in academic journals, ensuring proper...

Show all 12 in Medical Communications 6 more

Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
Medical Publications Make clear and accurate presentations of scientific and technical data.
Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.
Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...

Medical/Commercial

Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.

Old Category HEOR, RWE, Market Access

Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.

Pharmacovigilance

Pharmacovigilance Literature Surveillance Conduct systematic and ongoing review of scientific and medical literature to identify new information about the safety profile of a drug. This process is crucial for detecting adverse drug reactions (ADRs) that may...
Risk Management Plans (RMPs) Develop Risk Management plans (RMPs) that include information on a medicine's safety profile and plans for further pharmacovigilance activities designed to gain greater knowledge. These documents also explain how...

Primary Market Research

Asset Prioritization Studies Assesses stakeholder interest and unmet need across multiple assets in development. Helps pipeline teams allocate investment and identify lead candidates.
Behavioral Segmentation Groups stakeholders based on their actions and choices rather than demographics. Enables precise targeting and tailored intervention strategies.
Competitive Intelligence and Message Recall Measures awareness of competitor messaging and materials among stakeholders. Informs counter-positioning and promotional strategy.
Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
Conjoint analysis / Discrete Choice Modeling (DCM) Respondents evaluate hypothetical product profiles with varying features to identify trade-offs. Delivers utility scores for product attributes and preference shares to guide product and pricing strategy.
Cross-Functional Readouts and Workshops Interactive sessions to share findings and align stakeholders across functions. Enhances cross-team decision-making and execution planning.

Show all 27 in Primary Market Research 21 more

Early Concept Testing Evaluates initial ideas or positioning strategies with target audiences before refinement. Provides go/no-go input and direction for further development.
Generalists and specialists (e.g., oncologists, neurologists) Research targeting both broad-practice physicians and specialists to understand treatment preferences, diagnostic challenges, and clinical decision-making. Provides comparative insights for segmentation, messaging...
In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
Launch Readiness Assessments Evaluates internal and external preparedness for product launch, including sales force, market awareness, and access environment. Identifies gaps and supports launch planning.
Lifecycle Extension Concept Testing Tests ideas for extending the commercial life of a product (e.g., new formulations, indications). Supports long-term planning and investment decisions.
Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.
Message / Claims testing Iterative research to assess clarity, relevance, and impact of key messages. Delivers validated communications that align with stakeholder expectations.
Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
Pharmacy and Therapeutics (P&T) Committee Members - Market Research Research with formulary decision-makers to understand access requirements, value perceptions, and evidence expectations. Guides dossier development and value communication.
Policy Influencers - Market Research Qualitative or quantitative research with stakeholders who shape or advise on healthcare policy. Supports early stakeholder mapping and access scenario planning.
Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
Primary Market Research Primary market research, such as, focus groups, surveys, interviews and data collection field services.
Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
Regional and National Health Authorities - Market Research Interviews or surveys with government payers and HTA decision-makers to assess reimbursement criteria and policy landscapes. Used to shape market access strategies and prepare for pricing negotiations.
Segmentation and Profiling Divides target audiences into distinct groups based on attitudes, behaviours, or demographics. Informs tailored messaging and targeting strategies.
Sequential qual-quant studies Combines initial qualitative exploration with follow-up quantitative validation. Ensures both depth and scale in evaluating concepts, needs, or strategies.
Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.
Target Product Profile (TPP) Testing Tests stakeholder reactions to hypothetical product profiles across key attributes. Guides clinical development prioritization and access positioning.
Thematic Analysis Qualitative coding of transcripts or notes to identify recurring themes, patterns, and insights. Produces structured findings used to develop narratives and recommendations.

Real World Evidence & Data

Claims Data & Database Analysis Analysis of care cost and quality.
Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
Cohort Study Investigating the causes of disease to establish links between risk factors and health outcomes.
Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.

Show all 20 in Real World Evidence & Data 14 more

Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
Retrospective Exploratory Studies Retrospective exploratory studies
RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Website: genesisrg.com

United States Hoboken 1 site

Work with Genesis Research Group on Scientist.com

For prices, more details, or to contact Genesis Research Group, visit Scientist.com.

View on Scientist.com